Levothyroxine: Conventional and Novel Drug Delivery Formulations

Abstract

Despite the fact that levothyroxine is one of the most prescribed medications in the world, its bioavailability has been reported to be impaired by many factors, including interfering drugs or foods and concomitant diseases, and persistent hypothyroidism with a high dose of levothyroxine is thus elicited. Persistent hypothyroidism can also be induced by noninterchangeability between formulations and poor compliance. To address these issues, some strategies have been developed. Novel formulations (liquid solutions and soft-gel capsules) have been designed to eliminate malabsorption. Some other delivery routes (injections, suppositories, sprays, and sublingual and transdermal administrations) are aimed at circumventing different difficulties in dosing, such as thyroid emergencies and dysphagia. Moreover, nanomaterials have been used to develop delivery systems for the sustained release of levothyroxine to improve patient compliance and reduce costs. Some delivery systems encapsulating nanoparticles show promising release profiles. In this review, we first summarize the medical conditions that interfere with the bioavailability of oral levothyroxine and discuss the underlying mechanisms and treatments. The efficacy of liquid solutions and soft-gel capsules are systematically evaluated. We further summarize the novel delivery routes for levothyroxine and their possible applications. Nanomaterials in the levothyroxine field are then discussed and compared based on their load and release profile. We hope the article provides novel insights into the drug delivery of levothyroxine.

Thyroid Troubles: A Case of Hypothyroidism-Associated Recurrent Massive Pleural Effusion

“…The American Thyroid Association recommends an intravenous levothyroxine dose of 75% of the oral dose. Intravenous injection is firmly not recommended for long-term treatment due to its rapid and significant effect on thyroid hormone homeostasis [ 10 ]. Hence, intravenous treatment was pursued for three days only.…”

Unveiling The Effect of Testosterone Therapy on Sexual Dysfunction

“…), diverse administration routes (such as topical gel, topical cream, injection, sublingual, oral tablet, etc. ), and differing treatment durations (in accordance with trial specifications) (Liu et al, 2023). TTh could have been employed alongside concurrent non-testosterone-based therapies, which encompassed PDE-5 inhibitors, alprostadil, prostaglandins, vacuum therapy, and the like, for the purpose of addressing male sexual dysfunction.…”

Examining the Effects of Nutrient Supplementation on Metabolic Pathways via Mitochondrial Ferredoxin in Aging Ovaries

“…Nutrients 2024, 16, 1470 2 of 12 The consequences of ovarian aging include diminished reproductive capacity, infertility, and the onset of clinical symptoms like endocrine imbalances and irregular menstrual cycles [2].…”

“…T3, a thyroid hormone, governs a myriad of physiological processes encompassing growth, metabolism, body temperature, and heart rate [11]. With swifter and more potent physiological effects compared to thyroxine (T4), approximately 20% of T3 is directly secreted and synthesized by the thyroid gland, while the remaining 80% is converted from T4 in circulation [12]. T3's synthesis and secretion are stimulated by the thyroid-stimulating hormone (TSH) secreted by the pituitary gland, rendering it more biologically active than T4, despite its lower serum levels [13].…”